Attovia Therapeutics, Inc. · NASDAQ:ATTO
Frazier Life Sciences XI, L.P. reported a 13.50% stake in Attovia Therapeutics, Inc. (Schedule 13D)
Event Aug 6, 2026 · Filed Aug 11, 2026
Frazier Life Sciences XI, L.P. reported a 13.50% stake in Attovia Therapeutics, Inc., 6,154,213 shares, with active intent on Aug 6, 2026. Filed Aug 11, 2026 (Schedule 13D).
- Stake
- 13.50%
- Shares
- 6,154,213
- Intent
- Active
- What changed
- Crossed above 5%
- Filed together
- 9 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Frazier Life Sciences Public Fund, L.P. | 1.70% | 760,327 |
| FHMLSP, L.P. | 1.70% | 760,327 |
| FHMLSP, L.L.C. | 1.70% | 760,327 |
| Frazier Life Sciences XI, L.P. | 13.50% | 6,154,213 |
| FHMLS XI, L.P. | 13.50% | 6,154,213 |
| FHMLS XI, L.L.C. | 13.50% | 6,154,213 |
| Frazier Life Sciences XII, L.P. | 0.10% | 54,163 |
| FHMLS XII, L.P. | 0.10% | 54,163 |
| FHMLS XII, L.L.C. | 0.10% | 54,163 |
Source
Related
- Attovia Therapeutics, Inc.
- Frazier Life Sciences XI, L.P.
- Attovia Therapeutics, Inc. shareholders
- Form 4/A · Walsh Colin · Aug 28, 2026
- Form 4/A · Goldman Sachs Asset Management, L.P. · Aug 28, 2026
- Form 4 · Goldman Sachs & Co. LLC · Aug 13, 2026
- Schedule 13G · Deep Track Capital, LP · Aug 12, 2026
- Form 4 · venBio Global Strategic Fund IV, L.P. · Aug 10, 2026